Human Plasma s and Derivatives and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Human Plasma Products and Derivatives Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Plasma Products and Derivatives Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Plasma Products and Derivatives Overall Market Size
2.1 Global Human Plasma Products and Derivatives Market Size: 2021 VS 2028
2.2 Global Human Plasma Products and Derivatives Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Human Plasma Products and Derivatives Players in Global Market
3.2 Top Global Human Plasma Products and Derivatives Companies Ranked by Revenue
3.3 Global Human Plasma Products and Derivatives Revenue by Companies
3.4 Top 3 and Top 5 Human Plasma Products and Derivatives Companies in Global Market, by Revenue in 2021
3.5 Global Companies Human Plasma Products and Derivatives Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Plasma Products and Derivatives Players in Global Market
3.6.1 List of Global Tier 1 Human Plasma Products and Derivatives Companies
3.6.2 List of Global Tier 2 and Tier 3 Human Plasma Products and Derivatives Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Human Plasma Products and Derivatives Market Size Markets, 2021 & 2028
4.1.2 Coagulation Factor
4.1.3 Immune Globulin
4.1.4 Albumin
4.1.5 Others
4.2 By Type - Global Human Plasma Products and Derivatives Revenue & Forecasts
4.2.1 By Type - Global Human Plasma Products and Derivatives Revenue, 2017-2022
4.2.2 By Type - Global Human Plasma Products and Derivatives Revenue, 2023-2028
4.2.3 By Type - Global Human Plasma Products and Derivatives Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Plasma Products and Derivatives Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Others
5.2 By Application - Global Human Plasma Products and Derivatives Revenue & Forecasts
5.2.1 By Application - Global Human Plasma Products and Derivatives Revenue, 2017-2022
5.2.2 By Application - Global Human Plasma Products and Derivatives Revenue, 2023-2028
5.2.3 By Application - Global Human Plasma Products and Derivatives Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Human Plasma Products and Derivatives Market Size, 2021 & 2028
6.2 By Region - Global Human Plasma Products and Derivatives Revenue & Forecasts
6.2.1 By Region - Global Human Plasma Products and Derivatives Revenue, 2017-2022
6.2.2 By Region - Global Human Plasma Products and Derivatives Revenue, 2023-2028
6.2.3 By Region - Global Human Plasma Products and Derivatives Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Human Plasma Products and Derivatives Revenue, 2017-2028
6.3.2 US Human Plasma Products and Derivatives Market Size, 2017-2028
6.3.3 Canada Human Plasma Products and Derivatives Market Size, 2017-2028
6.3.4 Mexico Human Plasma Products and Derivatives Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Human Plasma Products and Derivatives Revenue, 2017-2028
6.4.2 Germany Human Plasma Products and Derivatives Market Size, 2017-2028
6.4.3 France Human Plasma Products and Derivatives Market Size, 2017-2028
6.4.4 U.K. Human Plasma Products and Derivatives Market Size, 2017-2028
6.4.5 Italy Human Plasma Products and Derivatives Market Size, 2017-2028
6.4.6 Russia Human Plasma Products and Derivatives Market Size, 2017-2028
6.4.7 Nordic Countries Human Plasma Products and Derivatives Market Size, 2017-2028
6.4.8 Benelux Human Plasma Products and Derivatives Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Human Plasma Products and Derivatives Revenue, 2017-2028
6.5.2 China Human Plasma Products and Derivatives Market Size, 2017-2028
6.5.3 Japan Human Plasma Products and Derivatives Market Size, 2017-2028
6.5.4 South Korea Human Plasma Products and Derivatives Market Size, 2017-2028
6.5.5 Southeast Asia Human Plasma Products and Derivatives Market Size, 2017-2028
6.5.6 India Human Plasma Products and Derivatives Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Human Plasma Products and Derivatives Revenue, 2017-2028
6.6.2 Brazil Human Plasma Products and Derivatives Market Size, 2017-2028
6.6.3 Argentina Human Plasma Products and Derivatives Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Human Plasma Products and Derivatives Revenue, 2017-2028
6.7.2 Turkey Human Plasma Products and Derivatives Market Size, 2017-2028
6.7.3 Israel Human Plasma Products and Derivatives Market Size, 2017-2028
6.7.4 Saudi Arabia Human Plasma Products and Derivatives Market Size, 2017-2028
6.7.5 UAE Human Plasma Products and Derivatives Market Size, 2017-2028
7 Players Profiles
7.1 Takeda
7.1.1 Takeda Corporate Summary
7.1.2 Takeda Business Overview
7.1.3 Takeda Human Plasma Products and Derivatives Major Product Offerings
7.1.4 Takeda Human Plasma Products and Derivatives Revenue in Global Market (2017-2022)
7.1.5 Takeda Key News
7.2 CSL
7.2.1 CSL Corporate Summary
7.2.2 CSL Business Overview
7.2.3 CSL Human Plasma Products and Derivatives Major Product Offerings
7.2.4 CSL Human Plasma Products and Derivatives Revenue in Global Market (2017-2022)
7.2.5 CSL Key News
7.3 Grifols
7.3.1 Grifols Corporate Summary
7.3.2 Grifols Business Overview
7.3.3 Grifols Human Plasma Products and Derivatives Major Product Offerings
7.3.4 Grifols Human Plasma Products and Derivatives Revenue in Global Market (2017-2022)
7.3.5 Grifols Key News
7.4 Octapharma
7.4.1 Octapharma Corporate Summary
7.4.2 Octapharma Business Overview
7.4.3 Octapharma Human Plasma Products and Derivatives Major Product Offerings
7.4.4 Octapharma Human Plasma Products and Derivatives Revenue in Global Market (2017-2022)
7.4.5 Octapharma Key News
7.5 Kedrion
7.5.1 Kedrion Corporate Summary
7.5.2 Kedrion Business Overview
7.5.3 Kedrion Human Plasma Products and Derivatives Major Product Offerings
7.5.4 Kedrion Human Plasma Products and Derivatives Revenue in Global Market (2017-2022)
7.5.5 Kedrion Key News
7.6 LFB Group
7.6.1 LFB Group Corporate Summary
7.6.2 LFB Group Business Overview
7.6.3 LFB Group Human Plasma Products and Derivatives Major Product Offerings
7.6.4 LFB Group Human Plasma Products and Derivatives Revenue in Global Market (2017-2022)
7.6.5 LFB Group Key News
7.7 Biotest
7.7.1 Biotest Corporate Summary
7.7.2 Biotest Business Overview
7.7.3 Biotest Human Plasma Products and Derivatives Major Product Offerings
7.7.4 Biotest Human Plasma Products and Derivatives Revenue in Global Market (2017-2022)
7.7.5 Biotest Key News
7.8 BPL
7.8.1 BPL Corporate Summary
7.8.2 BPL Business Overview
7.8.3 BPL Human Plasma Products and Derivatives Major Product Offerings
7.8.4 BPL Human Plasma Products and Derivatives Revenue in Global Market (2017-2022)
7.8.5 BPL Key News
7.9 RAAS
7.9.1 RAAS Corporate Summary
7.9.2 RAAS Business Overview
7.9.3 RAAS Human Plasma Products and Derivatives Major Product Offerings
7.9.4 RAAS Human Plasma Products and Derivatives Revenue in Global Market (2017-2022)
7.9.5 RAAS Key News
7.10 CBPO
7.10.1 CBPO Corporate Summary
7.10.2 CBPO Business Overview
7.10.3 CBPO Human Plasma Products and Derivatives Major Product Offerings
7.10.4 CBPO Human Plasma Products and Derivatives Revenue in Global Market (2017-2022)
7.10.5 CBPO Key News
7.11 Hualan Bio
7.11.1 Hualan Bio Corporate Summary
7.11.2 Hualan Bio Business Overview
7.11.3 Hualan Bio Human Plasma Products and Derivatives Major Product Offerings
7.11.4 Hualan Bio Human Plasma Products and Derivatives Revenue in Global Market (2017-2022)
7.11.5 Hualan Bio Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Human Plasma Products and Derivatives Market Opportunities & Trends in Global Market
Table 2. Human Plasma Products and Derivatives Market Drivers in Global Market
Table 3. Human Plasma Products and Derivatives Market Restraints in Global Market
Table 4. Key Players of Human Plasma Products and Derivatives in Global Market
Table 5. Top Human Plasma Products and Derivatives Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Human Plasma Products and Derivatives Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Human Plasma Products and Derivatives Revenue Share by Companies, 2017-2022
Table 8. Global Companies Human Plasma Products and Derivatives Product Type
Table 9. List of Global Tier 1 Human Plasma Products and Derivatives Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Plasma Products and Derivatives Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Human Plasma Products and Derivatives Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Human Plasma Products and Derivatives Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Human Plasma Products and Derivatives Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Human Plasma Products and Derivatives Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Human Plasma Products and Derivatives Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Human Plasma Products and Derivatives Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Human Plasma Products and Derivatives Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Human Plasma Products and Derivatives Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Human Plasma Products and Derivatives Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Human Plasma Products and Derivatives Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Human Plasma Products and Derivatives Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Human Plasma Products and Derivatives Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Human Plasma Products and Derivatives Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Human Plasma Products and Derivatives Revenue, (US$, Mn), 2023-2028
Table 30. Takeda Corporate Summary
Table 31. Takeda Human Plasma Products and Derivatives Product Offerings
Table 32. Takeda Human Plasma Products and Derivatives Revenue (US$, Mn), (2017-2022)
Table 33. CSL Corporate Summary
Table 34. CSL Human Plasma Products and Derivatives Product Offerings
Table 35. CSL Human Plasma Products and Derivatives Revenue (US$, Mn), (2017-2022)
Table 36. Grifols Corporate Summary
Table 37. Grifols Human Plasma Products and Derivatives Product Offerings
Table 38. Grifols Human Plasma Products and Derivatives Revenue (US$, Mn), (2017-2022)
Table 39. Octapharma Corporate Summary
Table 40. Octapharma Human Plasma Products and Derivatives Product Offerings
Table 41. Octapharma Human Plasma Products and Derivatives Revenue (US$, Mn), (2017-2022)
Table 42. Kedrion Corporate Summary
Table 43. Kedrion Human Plasma Products and Derivatives Product Offerings
Table 44. Kedrion Human Plasma Products and Derivatives Revenue (US$, Mn), (2017-2022)
Table 45. LFB Group Corporate Summary
Table 46. LFB Group Human Plasma Products and Derivatives Product Offerings
Table 47. LFB Group Human Plasma Products and Derivatives Revenue (US$, Mn), (2017-2022)
Table 48. Biotest Corporate Summary
Table 49. Biotest Human Plasma Products and Derivatives Product Offerings
Table 50. Biotest Human Plasma Products and Derivatives Revenue (US$, Mn), (2017-2022)
Table 51. BPL Corporate Summary
Table 52. BPL Human Plasma Products and Derivatives Product Offerings
Table 53. BPL Human Plasma Products and Derivatives Revenue (US$, Mn), (2017-2022)
Table 54. RAAS Corporate Summary
Table 55. RAAS Human Plasma Products and Derivatives Product Offerings
Table 56. RAAS Human Plasma Products and Derivatives Revenue (US$, Mn), (2017-2022)
Table 57. CBPO Corporate Summary
Table 58. CBPO Human Plasma Products and Derivatives Product Offerings
Table 59. CBPO Human Plasma Products and Derivatives Revenue (US$, Mn), (2017-2022)
Table 60. Hualan Bio Corporate Summary
Table 61. Hualan Bio Human Plasma Products and Derivatives Product Offerings
Table 62. Hualan Bio Human Plasma Products and Derivatives Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Human Plasma Products and Derivatives Segment by Type in 2021
Figure 2. Human Plasma Products and Derivatives Segment by Application in 2021
Figure 3. Global Human Plasma Products and Derivatives Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Human Plasma Products and Derivatives Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Human Plasma Products and Derivatives Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Human Plasma Products and Derivatives Revenue in 2021
Figure 8. By Type - Global Human Plasma Products and Derivatives Revenue Market Share, 2017-2028
Figure 9. By Application - Global Human Plasma Products and Derivatives Revenue Market Share, 2017-2028
Figure 10. By Region - Global Human Plasma Products and Derivatives Revenue Market Share, 2017-2028
Figure 11. By Country - North America Human Plasma Products and Derivatives Revenue Market Share, 2017-2028
Figure 12. US Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Human Plasma Products and Derivatives Revenue Market Share, 2017-2028
Figure 16. Germany Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 17. France Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Human Plasma Products and Derivatives Revenue Market Share, 2017-2028
Figure 24. China Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 28. India Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Human Plasma Products and Derivatives Revenue Market Share, 2017-2028
Figure 30. Brazil Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Human Plasma Products and Derivatives Revenue Market Share, 2017-2028
Figure 33. Turkey Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Human Plasma Products and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 37. Takeda Human Plasma Products and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. CSL Human Plasma Products and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Grifols Human Plasma Products and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Octapharma Human Plasma Products and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Kedrion Human Plasma Products and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. LFB Group Human Plasma Products and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Biotest Human Plasma Products and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. BPL Human Plasma Products and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. RAAS Human Plasma Products and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. CBPO Human Plasma Products and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Hualan Bio Human Plasma Products and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
